SCHEMBL11265442

SCHEMBL11265442

Cc1ncc2cnc(=O)c3ccccc3n12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.44
HSD17B10 Q99714 5/20 0.44
ALDH1A1 P00352 4/20 0.44
HPGD P15428 3/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
RCE1 Q9Y256 1/20 0.44
CHEK1 O14757 1/20 0.38
PTPN1 P18031 1/20 0.36
TSHR P16473 1/20 0.36
SMARCA4 P51532 4/20 0.36
GAA P10253 2/20 0.36
HTT P42858 2/20 0.36
GLA P06280 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPT P10636 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LCK P06239 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15887033 0.73 LCK (0.42) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL16695803 0.72 PARP1 (0.54) KDM4EALDH1A1HPGDCHEK1LCK
SCHEMBL5995444 0.70 KDM4E (0.53) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL6375117 0.70 GABRA5 (0.41) KDM4EHSD17B10ALDH1A1HPGDCHEK1
SCHEMBL11481100 0.67 KDM4E (0.48) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL7290888 0.67 ALDH1A1 (0.61) KDM4EHSD17B10ALDH1A1HPGDRCE1
SCHEMBL29352067 0.66 ALDH1A1 (0.43) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL1304538 0.66 ALDH1A1 (0.43) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL8614155 0.65 ALDH1A1 (0.49) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL6621756 0.64 KDM4E (0.52) KDM4EALDH1A1HPGDTSHRGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0059390-A1 Imidazodiazepines, intermediate products and process for their preparation, and medicines containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-09-08 EP disclosed